MAPT and Alzheimer disease: Similarly, it has been showed that tau strains derived from distinct human tauopathies are propagated in vivo through intracranial injections into wild-type mice and transgenic mouse models of AD; these pathologies closely recapitulate distinct features of human AD and its associated tauopathies [18].